tradingkey.logo
tradingkey.logo
Search

Lineage Cell Therapeutics Inc

LCTX
Add to Watchlist
0.915USD
-0.075-7.58%
Close 11-13 16:00(ET)
231.41MMarket Cap
LossP/E TTM
After-hours 18:30 (ET)0.915USD+0.005+0.55%

Today

-7.58%

5 Days

-10.29%

1 Month

-0.33%

6 Months

-30.15%

Year to Date

-45.21%

1 Year

-51.33%

Key Figures

0.990Open
1.125High
287.38KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.11%Turnover Ratio
0.990Prev. Close
0.890Low
273.93KTurnover
LossP/E Static
3.41P/B
0.00%Div Yield TTM
-57.86%ROA
1.99052wk High
0.23Volume Ratio
-18.61MNet Profit
252.91MShares
-0.2774EPS TTM
1.55Beta
-96.62%ROE
0.88252wk Low
23.74%Amplitude
99.65%Gross Margin
231.41MMarket Cap
-0.77Reward/Risk
3.51%Risk Rate
More news coming soon, stay tuned...

Lineage Cell Therapeutics Inc's Score

0.07vs previous score
Forecast8.00
Financial Health4.96
Technical4.13
Valuation Dimensions7.94
Institutional Confidence3.00
Risk Assessment4.03

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
5.500Target Price
+450.00%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy11111111
Buy55555655
Hold11111111
Sell00000000
Strong Sell00000000

Lineage Cell Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
0.02/-0.03
Revenue / Forecast
1.43M/1.99M

Lineage Cell Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolLCTX
Number of employees70
CountryUnited States of America

Ownership

ShareholdersProportion
Broadwood Capital, Inc.19.88%
Chernett (Jorey)4.59%
Vanguard Capital Management, LLC3.34%
Defender Capital LLC2.70%
Shareholder TypesProportion
Hedge Fund24.65%
Investment Advisor10.98%
Individual Investor4.93%
Investment Advisor/Hedge Fund2.56%

FAQs

What is the current price of Lineage Cell Therapeutics Inc (LCTX)?

The current price of Lineage Cell Therapeutics Inc (LCTX) is 0.92.

What is the symbol of Lineage Cell Therapeutics Inc?

The ticker symbol of Lineage Cell Therapeutics Inc is LCTX.

What is the 52-week high of Lineage Cell Therapeutics Inc?

The 52-week high of Lineage Cell Therapeutics Inc is 1.99.

What is the 52-week low of Lineage Cell Therapeutics Inc?

The 52-week low of Lineage Cell Therapeutics Inc is 0.88.

What is the market capitalization of Lineage Cell Therapeutics Inc?

The market capitalization of Lineage Cell Therapeutics Inc is 231.41M.

Is Lineage Cell Therapeutics Inc (LCTX) currently rated as Buy, Hold, or Sell?

According to analysts, Lineage Cell Therapeutics Inc (LCTX) has an overall rating of Buy, with a price target of 5.50.

What is the Earnings Per Share (EPS TTM) of Lineage Cell Therapeutics Inc (LCTX)?

The Earnings Per Share (EPS TTM) of Lineage Cell Therapeutics Inc (LCTX) is -0.28.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.